Literature DB >> 18976433

Positive association of HLA-DRB1*15 with keloid disease in Caucasians.

J J Brown1, W E R Ollier, W Thomson, A Bayat.   

Abstract

Keloid disease (KD) is a fibroproliferative dermal tumour of unknown aetiology. The increased familial clustering in KD, its increased prevalence in certain races and concordance in identical twins suggest a strong genetic predisposition to keloid formation. The most polymorphic genetic system in all vertebrates is the major histocompatibility complex (MHC) also known as the human leucocyte antigens (HLA) system. The MHC has been shown to be strongly associated with numerous conditions. Of particular interest is the association of DR2 with dermal fibrotic diseases such as sarcoidosis. To investigate the aetiology of KD, we compared the HLA-DRB1 phenotype frequencies of Caucasoid patients with keloid scars against those observed in a control population (n = 537). A total number of 67 keloid cases were evaluated in the study. HLA-DRB1 alleles were determined in all cases and controls using a commercially available semiautomated reverse hybridization polymerase chain reaction sequence-specific oligonucleotide probes typing system. HLA-DRB1*15 phenotype frequency was higher in KD-positive Caucasians (38.8%) when compared with controls (20.9%) (corrected P = 0.017). We conclude that in Caucasians of Northern European origin, HLA-DRB1*15 is associated with risk of developing KD following injury. We have demonstrated for the first time that a genetic association exists between HLA-DRB1*15 status and the risk of developing keloid scarring in Caucasians. Our data suggest the possible involvement of an immunogenic component to KD although the exact mechanisms involved in MHC-driven abnormal fibrosis will require further investigation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18976433     DOI: 10.1111/j.1744-313X.2008.00780.x

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN: 1744-3121            Impact factor:   1.466


  18 in total

Review 1.  Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies.

Authors:  Gerd G Gauglitz; Hans C Korting; Tatiana Pavicic; Thomas Ruzicka; Marc G Jeschke
Journal:  Mol Med       Date:  2010-10-05       Impact factor: 6.354

Review 2.  Advances in the pathogenesis and clinical application prospects of tumor biomolecules in keloid.

Authors:  Yijun Xia; Youbin Wang; Mengjie Shan; Yan Hao; Hao Liu; Qiao Chen; Zhengyun Liang
Journal:  Burns Trauma       Date:  2022-06-25

3.  Downregulated cytotoxic CD8+ T-cell identifies with the NKG2A-soluble HLA-E axis as a predictive biomarker and potential therapeutic target in keloids.

Authors:  Heng Xu; Zhu Zhu; Jian Hu; Jiawei Sun; Yan Wo; Xianshu Wang; Hongzhi Zou; Bin Li; Yixin Zhang
Journal:  Cell Mol Immunol       Date:  2022-01-17       Impact factor: 22.096

4.  Keloid scarring: understanding the genetic basis, advances, and prospects.

Authors:  Ahmad Sukari Halim; Azadeh Emami; Iman Salahshourifar; Thirumulu Ponnuraj Kannan
Journal:  Arch Plast Surg       Date:  2012-05-10

Review 5.  Genetic architecture of human fibrotic diseases: disease risk and disease progression.

Authors:  Agnès Gardet; Timothy S Zheng; Joanne L Viney
Journal:  Front Pharmacol       Date:  2013-12-18       Impact factor: 5.810

6.  Chemokine-Like Factor 1 (CKLF-1) is Overexpressed in Keloid Patients: A Potential Indicating Factor for Keloid-Predisposed Individuals.

Authors:  Mingzi Zhang; Ying Xu; Yifang Liu; Yingying Cheng; Pengxiang Zhao; Hao Liu; Youbin Wang; Xuemei Ma
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

7.  Genome-wide RNA-Sequencing analysis identifies a distinct fibrosis gene signature in the conjunctiva after glaucoma surgery.

Authors:  Cynthia Yu-Wai-Man; Nicholas Owen; Jonathan Lees; Aristides D Tagalakis; Stephen L Hart; Andrew R Webster; Christine A Orengo; Peng T Khaw
Journal:  Sci Rep       Date:  2017-07-17       Impact factor: 4.379

8.  Hyperbaric oxygen therapy can ameliorate the EMT phenomenon in keloid tissue.

Authors:  Mingzi Zhang; Shu Liu; Enling Guan; Hao Liu; Xinhang Dong; Yan Hao; Xin Zhang; Pengxiang Zhao; Xuehua Liu; Shuyi Pan; Youbin Wang; Xiaojun Wang; Yifang Liu
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

9.  Stem Cells in Keloid Lesions: A Review.

Authors:  Kim H Lim; Tinte Itinteang; Paul F Davis; Swee T Tan
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-05-16

10.  Is There an Association between Keloids and Blood Groups?

Authors:  Abas Mouhari-Toure; Bayaki Saka; Koussaké Kombaté; Sefako Akakpo; Palakiyem Egbohou; Kissem Tchangaï-Walla; Palokinam Pitche
Journal:  ISRN Dermatol       Date:  2012-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.